Abstract
Purpose
To identify predictors of incidental prostate cancer following Holmium laser enucleation of the prostate (HoLEP).
Methods
We retrospectively analyzed 458 consecutive patients who underwent HoLEP. Patients were classified into two groups: patients who received prostate biopsy prior to HoLEP (biopsy group, n = 174) and patients who did not (non-biopsy group, n = 284). The two groups were compared. Logistic regression analysis was performed to determine the predictive factors.
Results
A total of 27 patients (5.9 %) were incidentally diagnosed with prostate cancer. The incidence of prostate cancer was not significantly different between the two groups (biopsy group vs. non-biopsy group: 6.9 vs. 5.3 %, p = 0.48). Using multivariate analysis, a hypoechoic lesion identified by transrectal ultrasonography (TRUS) was the only predictor of incidental prostate cancer (odds ratio 2.829; 95 % confidence interval 1.061–7.539; p = 0.038). In the biopsy group, there were no significant differences in baseline characteristics including prostate size, prostate-specific antigen (PSA), PSA density, digital rectal examination (DRE) findings, and TRUS findings, between patients with and without prostate cancer. However, in the non-biopsy group, a hypoechoic lesion was found more frequently in patients with prostate cancer (prostate cancer vs. benign prostatic hyperplasia: 20.0 vs. 3.3 %, p = 0.02).
Conclusions
Prior negative prostate biopsy does not rule out the possibility of prostate cancer after HoLEP. The presence of a hypoechoic lesion on TRUS might be helpful to predict incidental prostate cancer after HoLEP in patients with normal PSA and negative DRE. Prostate biopsy prior to HoLEP should be considered in these patients.
Similar content being viewed by others
References
Murphy G, Natarajan N, Pontes J, Schmitz R, Smart C, Schmidt J, Mettlin C (1982) The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol 127(5):928–934
Endrizzi J, Optenberg S, Byers R, Thompson IM Jr (2001) Disappearance of well-differentiated carcinoma of the prostate: effect of transurethral resection of the prostate, prostate-specific antigen, and prostate biopsy. Urology 57(4):733–736
Jones JS, Follis HW, Johnson JR (2008) Probability of finding T1a and T1b (incidental) prostate cancer during TURP has decreased in the PSA era. Prostate Cancer Prostatic Dis 12(1):57–60
Zigeuner RE, Lipsky K, Riedler I, Auprich M, Schips L, Salfellner M, Pummer K, Hubmer G (2003) Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients. Urology 62(3):451–455
Yu X, Elliott SP, Wilt TJ, McBean AM (2008) Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies. J Urol 180(1):241–245
Aho T, Gilling P (2008) Current techniques for laser prostatectomy-PVP and HoLEP. Arch Esp Urol 61(9):1005–1013
Kim M, Lee HE, Oh SJ (2013) Technical aspects of holmium laser enucleation of the prostate for benign prostatic hyperplasia. Korean J Urol 54(9):570–579
Cho JY, Kim SH, Lee SE (2000) Peripheral hypoechoic lesions of the prostate: evaluation with color and power Doppler ultrasound. Eur Urol 37:443–448
Edge SB, Byrd DR, Compton CC et al (2010) Prostate. In: Edge SB, Byrd DR, Compton CC et al (eds) AJCC cancer staging manual, 7th edn. Springer, New York, pp 457–468
Nunez R, Hurd KJ, Noble BN, Castle EP, Andrews PE, Humphreys MR (2011) Incidental prostate cancer revisited: early outcomes after holmium laser enucleation of the prostate. Int J Urol 18(7):543–547
Kluth LA, Rink M, Schönsee B, Becker A, Hansen J, Balzer O, Reimann F, Budäus L, Heuer R, Spethmann J et al (2011) Holmium laser enucleation of the prostate (HoLEP) and incidental prostate cancer: clinical significance of histology in laser-prostatectomy in men < 70 years - an update. J Urol 185(4, Supplement):e841
Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, Valenti S, Vavassori I, Rigatti P (2008) Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center prospective randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 179(5, Supplement):S87–S90
Elzayat EA, Elhilali MM (2006) Holmium laser enucleation of the prostate (HoLEP): the endourologic alternative to open prostatectomy. Eur Urol 49(1):87–91
Das A, Kennett K, Sutton T, Fraundorfer M, Gilling P (2000) Histologic effects of holmium: YAG laser resection versus transurethral resection of the prostate. J Endourol 14(5):459–462
Naspro R, Freschi M, Salonia A, Guazzoni G, Di Girolamo V, Scattoni RCV, Rigatti P, Montorsi F (2004) Holmium laser enucleation versus transurethral resection of the prostate. Are histological findings comparable? J Urol 171(3):1203–1206
Vollmer RT: Prostate cancer and chip specimens (1986) Complete versus partial sampling. Hum Pathol 17(3):285–290
Krambeck AE, Handa SE, Lingeman JE (2013) Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol 189(1, Supplement):S141–S145
Seki N, Mochida O, Kinukawa N, Sagiyama K, Naito S (2003) Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the course of 70 consecutive cases. J Urol 170(5):1847–1850
Hurle R, Vavassori I, Piccinelli A, Manzetti A, Valenti S, Vismara A (2002) Holmium laser enucleation of the prostate combined with mechanical morcellation in 155 patients with benign prostatic hyperplasia. Urology 60(3):449–453
Son H, Ro YK, Min SH, Choo MS, Kim JK, Lee CJ (2011) Modified vaporization-resection for photoselective vaporization of the prostate using a GreenLight high-performance system 120-w laser: the Seoul technique. Urology 77(2):427–432
Kuntz RM, Ahyai S, Lehrich K, Fayad AMR (2004) Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 172(3):1012–1016
Mai KT, Isotalo PA, Green J, Perkins DG, Morash C, Collins JP (2000) Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screening. Arch Pathol Lab Med 124(10):1454–1456
Kim DK, Kim SJ, Moon HS, Park SY, Kim YT, Choi HY, Lee TY, Park HY (2010) The role of TURP in the detection of prostate cancer in BPH patients with previously negative prostate biopsy. Korean J Urol 51:313–317
Puppo P, Introini C, Calvi P, Naselli A (2006) Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer. Eur Urol 49:873–878
Zigeuner R, Schips L, Lipsky K, Auprich M, Salfellner M, Rehak P, Pummer K, Hubmer G (2003) Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies. Urology 62(5):883–887
Shim HB, Lee SE, Park HK, Ku JH (2007) Prostate biopsy in subjects with abnormal transrectal ultrasonography but normal digital examination findings and prostate-specific antigen levels. Int Urol Nephrol 39:1115–1120
Onur R, Littrup PJ, Pontes JE, Bianco FJ Jr (2004) Contemporary impact of transrectal ultrasound lesions for prostate cancer detection. J Urol 172:512–514
Conflict of interest
All authors have no direct or indirect commercial financial incentive associated with publishing the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kim, M., Song, S.H., Ku, J.H. et al. Prostate cancer detected after Holmium laser enucleation of prostate (HoLEP): significance of transrectal ultrasonography. Int Urol Nephrol 46, 2079–2085 (2014). https://doi.org/10.1007/s11255-014-0777-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0777-z